CYPH Cypherpunk Technologies Inc. - Common Stock
$0.86
Price · Aug 19, 2026
Fundamentals as of Aug 12, 2026
52W Range
$0–$4
17% of range
Analyst Rating
BUY
7 analysts
Price Target
$1
+5% upside
P/E (TTM)
12.3
ROE
6.1%
Net Profit Margin
—
CYPH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.86
Market Cap
$72M
P/E (TTM)
12.3
EPS (TTM)
$0.07
Revenue (TTM)
—
Div Yield
—
ROE
6.1%
Debt/Equity
—
52W Range
$0 – $4
CYPH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
2020-12-31
→
2021-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
Free Cash Flow
—
2017-12-31
→
2019-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CYPH
Peer Median
P/E (TTM)
12.3
—
P/S (TTM)
48.1
39.5
P/B
0.5
1.6
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CYPH
Peer Median
ROA
4.5%
-45.3%
ROE
6.1%
-98.8%
ROIC
-12.8%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CYPH
Peer Median
Current Ratio
35.6
5.7
Quick Ratio
3.1
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CYPH
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CYPH
Peer Median
CYPH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-08-14
Low
$0.90
High
$0.90
Median target
$0.90
+4.7%
Mean target
$0.90
+4.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.02%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Sept. 30, 2025 | $-0.08 | $-0.24 | 0.16% |
| June 30, 2025 | $-0.40 | $-0.30 | -0.10% |
| March 31, 2025 | $-0.37 | $-0.39 | 0.02% |
| Dec. 31, 2024 | $-0.37 | $-0.37 | -0.00% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| ELTX | — | -3.1 | — | — | — | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| RNTX | — | -0.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| XBIT | — | -1.6 | — | — | — | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $2M | $2M | |
| R&D Expense | $26M | $57M | $73M | $45M | $32M | $20M | |
| SG&A Expense | $11M | $13M | $14M | $12M | $11M | $10M | |
| Operating Expenses | $41M | $70M | $87M | $57M | $43M | $30M | |
| Operating Income | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M | |
| Interest Expense | · | · | · | $54.0K | $41.0K | $39.0K | |
| Pretax Income | $10M | $-67M | $-81M | $-54M | $-41M | $-28M | |
| Income Tax | $5M | $585.0K | · | $147.0K | $-24.0K | $-2.0K | |
| Net Income | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| EPS (Basic) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| EPS (Diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| Shares (Basic) | 66,140,346 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| Shares (Diluted) | 70,672,358 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| EBITDA | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M |
Balance Sheet 21
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $47M | $71M | $66M | $115M | $52M | |
| Prepaid Expense | $40.0K | $86.0K | $183.0K | $351.0K | $769.0K | $130.0K | |
| Current Assets | $162M | $48M | $72M | $68M | $117M | $52M | |
| PP&E (Net) | · | $5.0K | $5.0K | $20.0K | $36.0K | $65.0K | |
| PP&E (Gross) | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | |
| Accum. Depreciation | $226.0K | $221.0K | $221.0K | $206.0K | $190.0K | $161.0K | |
| Other Non-current Assets | · | · | · | $30.0K | $90.0K | · | |
| Total Assets | $163M | $49M | $73M | $70M | $118M | $54M | |
| Accounts Payable | $2M | $5M | $6M | $6M | $4M | $3M | |
| Accrued Liabilities | $2M | $9M | $6M | $5M | $5M | $3M | |
| Current Liabilities | $5M | $14M | $13M | $11M | $10M | $7M | |
| Capital Leases | · | · | · | $262.0K | $37.0K | $144.0K | |
| Deferred Tax | $5M | · | · | · | · | · | |
| Total Liabilities | $10M | $14M | $13M | $11M | $10M | $8M | |
| Common Stock | $84.0K | $38.0K | $26.0K | $10.0K | $88.0K | $60.0K | |
| Paid-in Capital | $616M | $503M | $460M | $377M | $372M | $270M | |
| Retained Earnings | $-463M | $-467M | $-400M | $-318M | $-264M | $-223M | |
| AOCI | $-95.0K | $-120.0K | $106.0K | $128.0K | $-267.0K | $-579.0K | |
| Stockholders' Equity | $154M | $35M | $60M | $59M | $108M | $47M | |
| Liabilities + Equity | $163M | $49M | $73M | $70M | $118M | $54M | |
| Shares Outstanding | 83,851,051 | 38,329,894 | 25,565,414 | 9,902,137 | 59,657,742 | 59,657,742 |
Cash Flow 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $5M | $4M | $3M | |
| Deferred Tax | $5M | · | · | $147.0K | $13.0K | $-42.0K | |
| Restructuring | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-44M | $-60M | $-44M | $-49M | $-35M | $-26M | |
| Investing Cash Flow | $-97M | · | $49M | · | · | $25.0K | |
| Financing Cash Flow | $108M | $37M | $-30.0K | $-210.0K | $98M | $74M | |
| Net Change in Cash | $-33M | $-23M | $5M | $-49M | $63M | $48M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2761.7% | -1902.6% | |
| Net Margin | · | · | · | · | -2705.8% | -1834.3% | |
| Pretax Margin | · | · | · | · | -2707.4% | -1834.4% | |
| EBITDA Margin | · | · | · | · | -2761.7% | -1902.6% | |
| ROA | 4.5% | -110.8% | -113.7% | -58.0% | -47.1% | -89.0% | |
| ROE | 6.1% | -160.8% | -123.2% | -84.7% | -36.1% | -55.1% | |
| ROIC | -12.8% | -201.6% | · | -96.7% | -38.4% | -61.2% |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 | 7.1 | |
| Quick Ratio | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 | 7.1 | |
| Interest Coverage | · | · | · | -1051.2 | -1010.4 | -731.8 |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 |
Growth Rates 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 0.00% | · |
Valuation (TTM) 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | |
| Net Income TTM | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| Market Cap | $97M | $110M | $106M | $397M | $2.86B | $1.34B | |
| P/E | 16.6 | -1.6 | -1.0 | -0.9 | -68.9 | -35.7 | |
| P/S | 64.8 | 73.5 | 70.6 | 265.0 | 1907.7 | 894.9 | |
| P/B | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Tangible Book | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Cash Flow | -2.2 | -1.8 | -2.4 | -8.1 | -81.4 | -51.7 | |
| Earnings Yield | 6.0% | -63.0% | -96.0% | -107.1% | -1.5% | -2.8% |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $197.0K | $161.0K | $975.0K | $1M | $11M | $13M | $13M | $15M | $18M | $11M | $12M | $12M | $11M | $39M | $11M | $12M | |
| SG&A Expense | $4M | $5M | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $3M | $17M | $16M | $16M | $18M | $21M | $15M | $15M | $15M | $15M | $43M | $14M | $15M | |
| Operating Income | $-5M | $-5M | $-5M | $-3M | $-17M | $-16M | $-16M | $-18M | $-21M | $-15M | $-15M | $-15M | $-15M | $-43M | $-14M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5.0K | $11.0K | |
| Pretax Income | $41M | $-82M | $45M | $-3M | $-17M | $-15M | $-16M | $-17M | · | · | $-12M | $-14M | · | · | · | · | |
| Income Tax | $2M | $-5M | $5M | $202.0K | · | · | $-123.0K | $708.0K | · | · | · | · | · | · | · | · | |
| Net Income | $39M | $-77M | $40M | $-3M | $-17M | $-15M | $-15M | $-18M | $-20M | $-14M | $-12M | $-14M | $-13M | $-42M | $-12M | $-15M | |
| EPS (Basic) | $0.21 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| EPS (Diluted) | $0.18 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| Shares (Basic) | 184,328,441 | 168,103,535 | -58,018,506 | 41,444,979 | 41,444,979 | 41,268,894 | -69,795,724 | 41,209,639 | 39,122,662 | 27,014,100 | -34,186,875 | 26,987,182 | 14,710,375 | 12,934,427 | -124,573,830 | 11,323,909 | |
| Shares (Diluted) | 217,343,013 | 168,103,535 | -53,486,494 | 41,444,979 | 41,444,979 | 41,268,894 | -69,795,724 | 41,209,639 | 39,122,662 | 27,014,100 | -34,186,875 | 26,987,182 | 14,710,375 | 12,934,427 | -124,573,830 | 11,323,909 | |
| EBITDA | $-5M | $-5M | · | $-3M | $-17M | $-16M | · | $-18M | $-21M | $-15M | · | $-15M | $-15M | $-43M | · | $-15M |
Balance Sheet 21
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $7M | $14M | $10M | $18M | $33M | $47M | $63M | $78M | $55M | $71M | $81M | $91M | $102M | $66M | $78M | |
| Prepaid Expense | $539.0K | $768.0K | $40.0K | $69.0K | $292.0K | $446.0K | $86.0K | $209.0K | $354.0K | $526.0K | $183.0K | $265.0K | $419.0K | $590.0K | $351.0K | $374.0K | |
| Current Assets | $138M | $82M | $162M | $10M | $19M | $34M | $48M | $64M | $80M | $56M | $72M | $82M | $94M | $105M | $68M | $80M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | · | · | · | $5.0K | $9.0K | $13.0K | $16.0K | $20.0K | $24.0K | |
| PP&E (Gross) | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | |
| Accum. Depreciation | · | · | $226.0K | · | · | · | $221.0K | · | · | · | $221.0K | · | · | · | $206.0K | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $15.0K | $30.0K | $45.0K | |
| Total Assets | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Accounts Payable | $588.0K | $516.0K | $2M | $4M | $7M | $6M | $5M | $6M | $8M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | |
| Accrued Liabilities | $1M | $2M | $2M | $4M | $7M | $7M | $9M | $9M | $7M | $4M | $6M | $5M | $5M | $4M | $5M | $5M | |
| Current Liabilities | $2M | $3M | $5M | $9M | $14M | $14M | $14M | $16M | $16M | $10M | $13M | $11M | $12M | $10M | $11M | $12M | |
| Capital Leases | · | · | · | · | · | · | · | · | $39.0K | $154.0K | · | · | $38.0K | $152.0K | $262.0K | $369.0K | |
| Deferred Tax | $2M | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4M | $3M | $10M | $9M | · | · | $14M | $16M | $16M | $11M | · | $11M | $12M | $11M | $11M | $12M | |
| Common Stock | $108.0K | $94.0K | $84.0K | $41.0K | $41.0K | $41.0K | $38.0K | $38.0K | $38.0K | $26.0K | $26.0K | $26.0K | $26.0K | $119.0K | $10.0K | $99.0K | |
| Paid-in Capital | $640M | $624M | $616M | $506M | $505M | $504M | $503M | $501M | $500M | $461M | $460M | $458M | $457M | $388M | $377M | $375M | |
| Retained Earnings | $-500M | $-540M | $-463M | $-503M | $-499M | $-483M | $-467M | $-452M | $-434M | $-413M | $-400M | $-387M | $-373M | $-360M | $-318M | $-306M | |
| AOCI | $-81.0K | $-86.0K | $-95.0K | $-104.0K | $-82.0K | $-113.0K | $-120.0K | $6.0K | $3.0K | $-120.0K | $106.0K | $760.0K | $414.0K | $355.0K | $128.0K | $690.0K | |
| Stockholders' Equity | $139M | $84M | $154M | $3M | $6M | $21M | $35M | $49M | $66M | $47M | $60M | $72M | $84M | $28M | $59M | $70M | |
| Liabilities + Equity | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Shares Outstanding | 107,764,382 | 93,927,528 | 83,851,051 | 41,439,529 | 41,439,529 | 41,439,529 | 38,329,894 | 38,264,464 | 38,264,464 | 25,603,417 | 25,565,414 | 25,565,414 | 25,565,414 | 119,410,992 | 9,902,137 | 99,021,376 |
Cash Flow 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $303.0K | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | $2M | $-5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $0 | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-7M | $-8M | $-14M | $-14M | $-16M | $-16M | $-14M | $-16M | $-10M | $-10M | $-10M | $-13M | $-13M | $-12M | |
| Investing Cash Flow | $-10M | $-9M | · | · | · | · | · | · | · | · | $0 | $0 | $-348.0K | $49M | · | · | |
| Financing Cash Flow | $13M | $5M | $108M | $-121.0K | $-119.0K | $-61.0K | $104.0K | $-66.0K | $37M | $29.0K | $0 | $-1.0K | $0 | $-29.0K | $0 | $0 | |
| Net Change in Cash | $935.0K | $-7M | $4M | $-8M | $-15M | $-15M | $-16M | $-16M | $24M | $-16M | $-10M | $-11M | $-11M | $37M | $-13M | $-13M |
Profitability 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 48.3% | -126.2% | · | -8.6% | -32.8% | -33.2% | · | -24.6% | -22.7% | -16.8% | · | -16.6% | -14.1% | -39.4% | · | -14.4% | |
| ROE | 54.3% | -146.7% | · | -12.8% | -46.6% | -45.3% | · | -30.0% | -26.9% | -36.5% | · | -19.3% | -16.0% | -66.0% | · | -16.2% | |
| ROIC | -3.2% | -5.3% | · | -125.1% | · | · | · | -38.0% | · | · | · | · | · | · | · | · |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 79.2 | 27.3 | · | 1.2 | 1.3 | 2.4 | · | 4.0 | 5.1 | 5.4 | · | 7.4 | 8.0 | 10.2 | · | 6.8 | |
| Quick Ratio | 4.4 | 2.2 | · | 1.1 | 1.3 | 2.3 | · | 3.9 | 5.0 | 5.3 | · | 7.3 | 7.8 | 9.9 | · | 6.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1389.8 |
Valuation (TTM) 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-58M | $-113M | · | $-54M | $-70M | $-68M | · | $-66M | $-61M | $-83M | · | $-84M | $-87M | $-84M | · | $-54M | |
| Market Cap | $66M | $75M | · | $19M | $12M | $13M | · | $98M | $75M | $68M | · | $35M | $80M | $406M | · | $871M | |
| P/E | -0.8 | -0.6 | · | -0.4 | -0.2 | -0.2 | · | -1.3 | -0.8 | -0.5 | · | -0.2 | -0.4 | -0.6 | · | -2.9 | |
| P/S | 44.0 | 49.8 | · | 12.5 | 8.2 | 8.4 | · | 65.6 | 50.0 | 45.4 | · | 23.5 | 53.3 | 270.7 | · | 580.9 | |
| P/B | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Tangible Book | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Cash Flow | · | -21.8 | · | · | · | -0.9 | · | · | · | -4.4 | · | · | · | -32.0 | · | · | |
| Earnings Yield | -124.2% | -164.8% | · | -284.1% | -582.5% | -603.3% | · | -77.0% | -125.0% | -194.4% | · | -434.1% | -223.0% | -181.2% | · | -34.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $2M |
| Operating Margin % | — | — | — | — | -2761.7% |
| Net Income | $5M | $-68M | $-81M | $-55M | $-41M |
| Diluted EPS | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 |
| Quick Ratio | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 57 filers · $11.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 16 (+4 vs prior Q) | 5 (-3 vs prior Q) | 18 (+11 vs prior Q) | 7 (-3 vs prior Q) | +8.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2,379,195 | 3,887,574 | 21.09% | Shares |
| VANGUARD GROUP INC | $2,109,360 | 1,818,414 | 18.70% | Shares |
| BlackRock, Inc. | $1,605,955 | 2,622,823 | 14.24% | Shares |
| JANE STREET GROUP, LLC | $735,051 | 1,200,476 | 6.52% | Shares |
| UBS Group AG | $655,970 | 1,071,847 | 5.82% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $534,947 | 873,464 | 4.74% | Shares |
| CITADEL ADVISORS LLC | $511,976 | 836,153 | 4.54% | Shares |
| XTX Topco Ltd | $390,849 | 638,329 | 3.47% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $355,752 | 583,200 | 3.15% | Call option |
| VANGUARD FIDUCIARY TRUST CO | $349,663 | 571,345 | 3.10% | Shares |
| STATE STREET CORP | $316,016 | 516,113 | 2.80% | Shares |
| CITADEL ADVISORS LLC | $259,003 | 423,000 | 2.30% | Call option |
| NORTHERN TRUST CORP | $135,950 | 222,031 | 1.21% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $123,220 | 202,000 | 1.09% | Put option |
| JANE STREET GROUP, LLC | $107,826 | 176,100 | 0.96% | Call option |
| LPL Financial LLC | $97,474 | 159,194 | 0.86% | Shares |
| Sequoia Financial Advisors, LLC | $93,376 | 152,500 | 0.83% | Shares |
| HighTower Advisors, LLC | $61,585 | 100,580 | 0.55% | Shares |
| JANE STREET GROUP, LLC | $53,637 | 87,600 | 0.48% | Put option |
| TWO SIGMA INVESTMENTS, LP | $49,236 | 80,411 | 0.44% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46,726 | 76,313 | 0.41% | Shares |
| Key Client Fiduciary Advisors, LLC | $45,985 | 75,102 | 0.41% | Shares |
| Toroso Investments, LLC | $40,964 | 35,314 | 0.36% | Shares |
| Farther Finance Advisors, LLC | $27,458 | 44,844 | 0.24% | Shares |
| Texas Capital Bank Wealth Management Services Inc | $23,022 | 37,600 | 0.20% | Shares |
| Simplify Asset Management Inc. | $17,132 | 27,979 | 0.15% | Shares |
| CITADEL ADVISORS LLC | $16,716 | 27,300 | 0.15% | Put option |
| Spark Investment Management LLC | $15,859 | 25,900 | 0.14% | Shares |
| Gerber Kawasaki Wealth & Investment Management | $13,470 | 22,000 | 0.12% | Shares |
| GROUP ONE TRADING LLC | $13,130 | 21,444 | 0.12% | Shares |
| Qube Research & Technologies Ltd | $9,639 | 15,742 | 0.09% | Shares |
| Tower Research Capital LLC (TRC) | $8,972 | 14,653 | 0.08% | Shares |
| BARCLAYS PLC | $8,463 | 13,821 | 0.08% | Shares |
| Keystone Financial Group | $7,172 | 11,712 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $7,105 | 11,609 | 0.06% | Shares |
| SIMON QUICK ADVISORS, LLC | $6,958 | 11,364 | 0.06% | Shares |
| Quadrant Private Wealth Management, LLC | $6,858 | 11,200 | 0.06% | Shares |
| IHT Wealth Management, LLC | $6,735 | 11,000 | 0.06% | Shares |
| Key Client Fiduciary Advisors, LLC | $6,735 | 11,000 | 0.06% | Call option |
| Scientech Research LLC | $6,238 | 10,187 | 0.06% | Shares |
| BLAIR WILLIAM & CO/IL | $6,123 | 10,000 | 0.05% | Shares |
| ADIRONDACK TRUST CO | $6,100 | 10,000 | 0.05% | Shares |
| SIMPLEX TRADING, LLC | $2,709 | 4,427 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $1,128 | 1,850 | 0.01% | Shares |
| HUNTINGTON NATIONAL BANK | $612 | 1,000 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $431 | 704 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $144 | 227 | 0.00% | Shares |
| Cygnus Capital Advisors, LLC | $135 | 11,492 | 0.00% | Shares |
| Allworth Financial LP | $83 | 135 | 0.00% | Shares |
| TOMPKINS FINANCIAL CORP | $73 | 120 | 0.00% | Shares |
| FMR LLC | $61 | 100 | 0.00% | Shares |
| Virtu Financial LLC | $53 | 86,789 | 0.00% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $31 | 50 | 0.00% | Shares |
| MORGAN STANLEY | $1 | 1 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
| PlanVest Financial, Inc | $1 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 200 | 0.00% | Shares |
Company insiders 21 insiders · 7 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | July 1, 2026 A | 106,858 | 0 | 2 | $-2,123,642 |
| Augustine Lawlor | Chief Operating Officer | March 28, 2025 M | 19,789 | 0 | 0 | $0 |
| William Patrick Mcevoy III | Chief Investment Officer | July 1, 2026 A | — | 0 | 0 | $0 |
| Jason Baum | Chief Scientific Officer | March 28, 2025 M | 15,896 | 0 | 0 | $0 |
| Christine Granfield | VP, Head of Reg Affairs/Qual | March 28, 2025 M | 15,896 | 0 | 0 | $0 |
| John Mark O'Mahony | Chief Manufacturing Officer | March 28, 2025 M | 27,500 | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | March 28, 2025 M | 27,500 | 0 | 0 | $0 |
| Khing Djien Oei | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Patricia A. Martin | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Christian M Richard | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Thomas John Dietz | Director | July 1, 2026 A | 152,500 | 0 | 0 | $0 |
| Nissim Mashiach | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| William Li | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Christopher Mirabelli | Director | March 26, 2026 S | 130,376 | 0 | 3 | $-2,166,242 |
| Richard Schilsky | Director | March 13, 2026 M | 168,750 | 0 | 0 | $0 |
| Joseph Loscalzo | Director | March 13, 2026 M | 168,750 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Director | March 13, 2026 M | 168,963 | 0 | 1 | $-822,178 |
| John W Littlechild | Director | March 2, 2020 A | — | 0 | 0 | $0 |
| Harold R Werner | 10% owner | July 30, 2018 J | — | 0 | 0 | $0 |
| Eli Lilly and Company | 10% owner | July 30, 2018 A | — | 0 | 0 | $0 |
| Monica Bertagnolli | — | Jan. 31, 2022 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Winklevoss Capital Fund, LLC, Winklevoss Treasury Investments, LLC, Winklevoss Capital Management, LLC, Tyler Howard Winklevoss, Cameron Howard Winklevoss ×2 filings | Nov. 21, 2025 | 19.90% | Amendment | — | SEC |
| BeiGene, Ltd. ×4 filings | Oct. 31, 2024 | 0.00% | Amendment | — | SEC |
| Valence Helix Investments III, LLC, Valence Helix Investments, LLC, Eric Roberts, Graham Crooke, Rachel Leheny, Philip Sawyer, Evgeny Zaytsev ×2 filings | Jan. 21, 2020 | — | Initial filing | — | SEC |
| HealthCare Ventures IX, L.P., HealthCare Partners IX, L.P., HealthCare Partners IX, LLC, HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, HealthCare Ventures Strategic Fund, L.P., HealthCare Strategic Partners, LLC, Christopher Mirabelli, Augustine Lawlor, Douglas E. Onsi, James H. Cavanaugh, John W. Littlechild, Harold Werner ×4 filings | Feb. 8, 2019 | — | Initial filing | Capital structure | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.